Up-to-date news about Intravacc
Stay informed about the latest developments in our mission to pioneer transformative vaccines with up-to-date corporate communications. Get the latest news on our development and business milestones, as well as industry insights, partnership announcements, and corporate reports.
![](/fileadmin/_processed_/a/7/csm_press-primrose-0324_531f92af1a.jpg)
Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine Development
![](/fileadmin/_processed_/9/9/csm_press-Avacc10-0324_7afcdc4fae.jpg)
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
![](/fileadmin/_processed_/2/3/csm_CARB-X_18a889ad18.jpg)
Intravacc secures $633K funding from CARB-X to develop a vaccine against Neisseria gonorrhoeae.
![](/fileadmin/_processed_/7/b/csm_New_website_2-1_412485ae56.jpg)
We are thrilled to announce the launch of our new website!
![inVitro 01 inVitro 01](/fileadmin/_processed_/a/d/csm_inVitro-01_3fc0648481.jpg)
In vitro alternative assay to the replace rabbit pyrogen test for vaccines.
![](/fileadmin/_processed_/e/2/csm_press-9_b37966bc1b.jpg)
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
![](/fileadmin/_processed_/a/e/csm_ALS_Avacc31_5f899446cb.jpg)
Intravacc and DZNE awarded EU funding to develop vaccine against genetic ALS variant
![press 1 press 1](/fileadmin/_processed_/e/b/csm_press-1_c743651ace.jpg)
Intravacc’s inactivated polio vaccine, out licensed to Sinovac, receives market authorization in China
![press 17 press 17](/fileadmin/_processed_/c/1/csm_press-17_6ca077aac8.jpg)
Intravacc announces positive pre-clinical data for its SARS-CoV-2 nose spray vaccine
![](/fileadmin/_processed_/4/1/csm_corporate-5_330417d8ce.jpg)
Intravacc announces positive pre-clinical data for its OMV-based Lyme vaccine